Ian was Chief Financial Officer and Chief Business Officer at Elucida Oncology, and Chief Financial Officer at TCR2 Therapeutics. Ian Somaiya joined NewAmsterdam Pharma in 2024.
Ian Somaiya is currently
Create your alert
to follow the career of Ian Somaiya.
Ian Somaiya has a Bachelor of Arts in Biology and Neuroscience from New York University..
Do you need to know more about Ian Somaiya? More results.
Report an error
Update the org chart details of Ian Somaiya.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.